Primary SS | Secondary SS | p Value | ||||||
Group A infected HVC (n=3) | Group B ELISA HVC indeterminate (n=3) | Group C not HVC infected (n=15) | Group D not HVC infected (n=15) | |||||
Diffuse lymphocytic infiltrate
| ||||||||
CD3 | +++ | +++ | +++ | +++ | NS | |||
CD4 | ++ | ++ | ++ | ++ | NS | |||
CD8 | ++ | ++ | ++ | ++ | NS | |||
CD20 | + | ++ | + | ++ | NS | |||
CD25 | + | + | + | ++ | NS | |||
HLA-DR | ++ | ++ | ++ | ++ | NS | |||
Lymphocytic focus
| ||||||||
Mean score1-150 | 1.00 | 1.6 | 2.6 | 0.9 | ||||
CD3 | + | ++ | +++ | ++ | NS | |||
CD20 | +++ | ++ | + | + | <0.05 | |||
CD25 | + | + | + | + | NS | |||
HLA-DR | + | ++ | ++ | ++ | NS | |||
Epithelial cells
| ||||||||
CD25 | + | + | ++ | ++ | NS | |||
HLA-DR | ++ | ++ | ++ | ++ | NS |
↵1-150 Daniels’s score.15
SS = Sjögren’s syndrome, HVC = hepatitis virus C, + = 5–25% positive cells, ++ = 25–50% positive cells, +++ = 50–75% positive cell.